| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |